Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ushasree Ravula"'
Publikováno v:
Asian Journal of Medical Sciences, Vol 13, Iss 2, Pp 18-26 (2022)
Background: COVID-19 is an emerging and rapidly evolving situation globally, and it poses additional burden for emergency health care services especially the transfusion medicine and the need of an hour to safeguard our regular blood donors. Aim a
Externí odkaz:
https://doaj.org/article/b87bcb2bea134ff1988f5d96582fdc7f
Publikováno v:
Indian Journal of Obstetrics and Gynecology Research. 9:71-76
Maternal alloimmunization is still the leading cause of fetal anemia and is responsible for neonatal mortality and morbidity in developing countries. Evidence-based guidelines are essential for implementing antenatal alloantibodies screening in devel
Autor:
Srinivasa Rao Chunchu, Ushasree Ravula, Vikram Kumar Gente, Srinivas Bacchu, S. Pandu Ranga Rao, Srujaleswari Mooli
Publikováno v:
Indian Journal of Hematology & Blood Transfusion
The current study aimed to estimate the seroprevalence of SARS-CoV-2 IgG (S-protein) antibodies along with neutralizing assay (RBD-domain) among the whole blood donors without any prior Covid-19 history or symptoms visiting Blood Centre at a Tertiary
Publikováno v:
Transfusion and Apheresis Science. 62:103519
The study aimed to analyze social media platforms usage by blood donors, their responses to blood donation requests, most engaging ways of blood donor motivation from a donor perspective, and compare across different generations of blood donors.This
Autor:
Ariyanachi K, Chennakesavulu Dara, Srinivas M, Ushasree Ravula, Triven Sagar Sandepogu, Saranya Mallamgunta, Lakshmi J. Tadi, Srinivasa Rao Chunchu
Publikováno v:
Cureus
Introduction The SARS-CoV-2 illness (COVID-19) has spread around the world, primarily through person-to-person transmission, and is a serious public health concern. Based on the severity of illness symptoms, SARS-CoV-2 infection can be classified as
Autor:
Ushasree. Ravula, Srinivasa Rao Chunchu, Srujaleswari Mooli, Ravi Naik, Pandu Ranga Rao Sarangapati
Publikováno v:
Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine. 29(2)
Though moderate to severely ill COVID-19 patients are being treated using COVID Convalescent plasma across the world, there is a lack of standardization or information about the relative neutralizing capacity of antibodies from convalescent plasma do
Publikováno v:
Transfusion and Apheresis Science
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), has led to a global pandemic. However, the majority of currently available data are restricted to laboratory-confirmed cases for